ARS Pharmaceuticals, Inc.SPRY

$9.65-0.25 (-2.53%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$958M

Small-cap

+8%

2020 — today

10-Year Price

-62%

2020 — today

52-Week Range

$6.73$18.35

Current $9.65· 25%

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.

Valuation in context

P/E ratio

-4.8

N/A

Not meaningful — company is unprofitable

P/B ratio

15.6

Near historic high

Near historic highs — last 10 years

FCF Yield

-18.3%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when SPRY is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.